2006

1. Ritonavir-boosted tipranavir demonstrates superior efficacy to ritonavir-boosted protease inhibitors in treatment-experienced HIV-infected patients: 24-Week results of the RESIST-2 trial

   Clinical Infectious Diseases, Vol. 43, Núm. 10, pp. 1347-1356